Alkermes (ALKS) Return on Capital Employed Growth (3y) (2014 - 2026)
Alkermes (ALKS) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -1,755.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,755.00 |
| Mar 31, 2026 | 626.00 |
| Dec 31, 2025 | 1,404.00 |
| Sep 30, 2025 | 1,921.00 |
| Jun 30, 2025 | 1,934.00 |
| Mar 31, 2025 | 1,838.00 |
| Dec 31, 2024 | 1,929.00 |
| Sep 30, 2024 | 2,222.00 |
| Jun 30, 2024 | 2,151.00 |
| Mar 31, 2024 | 3,394.00 |
| Dec 31, 2023 | 3,216.00 |
| Sep 30, 2023 | 3,373.00 |
| Jun 30, 2023 | 2,976.00 |
| Mar 31, 2023 | 993.00 |
| Dec 31, 2022 | 1,220.00 |
| Sep 30, 2022 | 1,248.00 |
| Jun 30, 2022 | 1,368.00 |
| Mar 31, 2022 | 1,343.00 |
| Dec 31, 2021 | 1,317.00 |
| Sep 30, 2021 | 231.00 |